Torsade de pointes (TdP) arrhythmia is a potentially fatal form of ventricular arrhythmia that occurs under conditions in which cardiac repolarization is delayed (as indicated by prolonged QT intervals in electrocardiograph recordings).
More than 100 non-cardiovascular drugs can induce TdP arrhythmias or QT interval prolongations in electrocardiograms. [6] [7] [8] [9] Regulatory guidelines [CPMP/986/96 (1997) and ICH S7B (2005) ] recommend the use of preclinical in vivo and in vitro (in which a broad range of concentrations should be used) studies to detect the QT-prolonging effects and arrhythmogenic potential of new chemical entities. [10] [11] [12] The HERG assay (which tests I Kr ) is one of the recommended in vitro models for the detection of potential drug-induced long QT. 11) Sophocarpine (SC) is a dehydroderivative of the bis-quinolizidine alkaloid matrine. 13) In China, it has entered clinical development as an injection solution with a superior inhibitory effect on Coxsackie B virus that should result in improved efficacy in the treatment of viral myocarditis. [14] [15] [16] [17] The inhibitory actions of several matrine-type alkaloids on I Kr have recently been reported. 18, 19) We investigated the effects of SC on HERG-encoded K ϩ channels to assess the risk of this drug causing cardiac arrhythmia associated with QT interval prolongation.
We set out to establish: (i) the effects of SC on the amplitude, concentration dependence and kinetics of currents conducted by HERG channels stably expressed in human embryonic kidney (HEK293) cells. This was done using a wholecell patch clamp method; and (ii) the effects of SC on HERG protein levels in HEK293 cells. This was achieved using Western blot analysis and immunofluorescence methods.
MATERIALS AND METHODS

HERG-Expressing Cell Lines
Experiments were performed on HEK293 cells that stably expressed the wild-type HERG gene (provided by Professor Zhi-Guo Wang, Montreal Heart Institute, Montreal, Canada). Cells were maintained in Dulbecco's Modified Eagle's Medium (DMEM, Hyclone) supplemented with 10% (v/v) fetal calf serum (FCS, Gibco) and 200-mM geneticin (G-418, Gibco) at 37°C in a humidified atmosphere of 5% CO 2 .
Sophocarpine SC (Dushun Ltd., Ningxia, China) was dissolved in deionized water to obtain a 10-mM stock solution, which was stored at Ϫ20°C.
Electrophysiological Recordings HERG currents were measured using the whole-cell configuration of the patch clamp technique. 8, 9, 20) Heat-polished patch pipettes had final resistances of 2-4 MW when filled with a pipette solution containing (in mM): 130 KCl, 1 MgCl 2 · 6H 2 O, 10 HEPES, 5 Mg-ATP, 5 EGTA and 0.1 guanosine triphosphate (GTP) (pH 7.3 with KOH). The extracellular solution contained (in mM): 136 NaCl, 5.4 KCl, 5 HEPES, 1 MgCl 2 · 6H 2 O, 1 CaCl 2 and 10 glucose (pH 7.4 with NaOH). The final drug concentrations were prepared daily from SC stock solution by diluting with extracellular solution.
For electrophysiological recordings, submaximally confluent cells were used after 1-3 d of culture at a seeding density of 1-4ϫ10 5 cells per flask (Corning). The cells were harvested from the flask by treatment with 0.25% trypsin and 0.02% EDTA, and transferred to the recording chamber where they were allowed to attach to the glass bottom for ca. 10 min. The bath was then perfused continuously at a rate of 1.5 ml min
Ϫ1
. Recordings were taken at room temperature (22-24°C) using an Axopatch-200B amplifier controlled by pCLAMP 9.2 (Axon Instruments), beginning 5 min after cell rupture to enable dialysis. Capacitance and series resistance compensation were optimized. Data were recorded on a computer via Digidata 1322A, and analysed using pCLAMP Graphical fits of the data were made using previously described standard equations. 21, 22) Western Blot Analysis The expression of high levels of HERG protein was monitored using Western blot experiments. Cells were incubated at 37°C in DMEM both with and without SC for different periods of time. The cells were then harvested from the flask using ice-cold phosphatebuffered saline, and total protein was extracted. Protein concentration was determined according to the Bradford method (Sigma), with bovine albumin as a standard. Protein expression was determined using Western blot analysis and expressed as a ratio with levels of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Denatured protein was separated using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), transferred to nitrocellulose membranes (Stratagene) and incubated with primary antibodies against GAPDH (Affinity Reagents) and specific polyclonal rabbit anti-HERG antibody (Santa Cruz Biotechnology) at 1 : 200 dilution. Goat anti-rabbit Alexa Fluor 700 (dilution 1 : 4000, Molecular Probes) was used as a secondary antibody. The Odyssey infrared fluorescent scanning system (LI-COR) was used to detect membrane proteins. The band densities were quantified by densitometry, using Scion Image software.
Immunofluorescence Cells were seeded onto sterile glass coverslips within 35 mm tissue culture dishes. After 48 h of incubation in DMEM without and with drug, culture media were removed and cells were fixed in 4% paraformaldehyde in PBS for 10 min at room temperature. After three washes with PBS, cells were permeabilized for 1 h with 0.4% Triton X-100 in PBS (PBS-Tr), washed and then blocked in PBS, containing 5% bovine serum albumin (BSA), for 5 h at room temperature. Cells were incubated overnight at 4°C with primary antibody (rabbit anti-HERG, dilution 1/200) in PBS. After rewarming, cells were incubated in the dark with the secondary antibody [goat anti-rabbit Alexa Fluor 488 (Molecular Probes)] at 1 : 200 dilution for 2 h at room temperature. Samples were washed with PBS before mounting onto the overslips for examination using laser confocal microscopy (OLYMPUS). Control and treated cells were cultured and prepared for microscopy in parallel.
Statistics Data are presented as meanϮstandard error of the mean (S.E.M.), with the exception of IC 50 . Statistical comparisons were made using a two-tailed Student's t-test. pValues Ͻ0.05 were interpreted as being statistically significant.
RESULTS
Inhibition of HERG K
؉ Currents by SC The HERG current was elicited from the holding potential of Ϫ80 mV by test pulses ranging from Ϫ60 to ϩ40 mV in 10-mV steps. The test pulses each had a 4-s duration and were applied every 8 s. Each test pulse was followed by a repolarization step to Ϫ50 mV, which evoked large, slowly decaying outward tail-currents. Currents were recorded first under control conditions, and then SC (300 mM) was washed into the bath for 10 min, with the cell kept at the holding potential, before current recording commenced in the presence of drug (Fig.  1A) . In the absence of drug, the I-V relationship exhibited the characteristic bell-shape that increased from Ϫ40 to Ϫ10 mV and, due to the fast C-type inactivation of HERG channels; it decreased with further depolarization. 23 ) SC reduced both the HERG current (I step ) during the test potentials and the tail current (I tail ), with the latter inhibited by 56.0Ϯ2.4% (nϭ12) after a test pulse to 0 mV (Fig. 1B) . The half-maximal activation voltage (V 1/2 ) shifted slightly after exposure to SC, from Ϫ19.4Ϯ1.7 mV in the control to Ϫ20.2Ϯ1.3 mV (pϾ0.05, nϭ12). The slope factor (k) was significantly affected, changing from 7.4Ϯ0.2 mV in the control to 6.6Ϯ0.2 mV following exposure to SC ( pϽ0.05, nϭ12). SC inhibited the tail current at all potentials, although voltage dependence was evident with a significantly weaker block at more negative potentials (Fig. 1B) .
Concentration-Dependent Block SC blocked HERG currents and the tail current in a concentration-dependent manner. The stimulus protocol used is shown in Fig. 1A . At SC concentrations of 10, 30, 100 and 300 mM, the HERG current amplitude at 0 mV and the peak tail-current amplitude were measured, normalized for each cell to the control value and then averaged (nϭ12). Fractional block of I step was (A) Representative HERG current traces in control and in the presence of 300-mM SC (lower panels) recorded in response to the voltage protocol shown (upper panels). The HERG current was elicited from the holding potential of Ϫ80 mV by test pulses ranging from Ϫ60 to ϩ40 mV. The test pulses each had a 4-s duration and were applied every 8 s. Each test pulse was followed by a repolarization step to Ϫ50 mV, which evoked large, slowly decaying outward tail-currents. (B) Normalized I-V relationships for current measured at the end of depolarizing steps (left panel) and tail current (right panel) in the absence and presence of 300-mM SC. (C) Mean fractional block of I step at a test potential of 0 mV, and the peak tail-current amplitude at SC concentrations of 10, 30, 100 and 300 mM were determined in HEK293 cells that stably expressed HERG channels. * pϽ0.05, * * pϽ0.01, * * * pϽ0.001 vs. control. 10 .7Ϯ2.8% in the 10-mM group (pϾ0.05), 11.3Ϯ5.5% in the 30-mM group (pϾ0.05), 47.0Ϯ2.3% in the 100-mM group (pϽ0.01) and 53.7Ϯ2.5% in the 300-mM group (pϽ0.001); the corresponding fractional blocks of I tail were 1.1Ϯ3.0% (pϾ0.05), 17.1Ϯ3.3% ( pϾ0.05), 32.7Ϯ1.9% ( pϽ0.05) and 56.0Ϯ2.4% (pϽ0.001), respectively. Thus, compared with the control, 100-mM SC and 300-mM SC had statistically significant inhibitory effects on I step and I tail (Fig. 1C) . The IC 50 of SC was 100-300 mM. Inhibition of the HERG current was partly reversed by drug washout (not shown).
Effects of SC on HERG Channel Kinetics Drugs that block ion channels often alter the voltage dependence or kinetics of channel gating. Therefore, we examined the effects of SC on the voltage dependence of activation and rectification and on the kinetics of inactivation and deactivation.
The activation curves were constructed by normalizing the tail currents recorded with the protocol used in Fig. 1A . The normalized data were plotted against the test pulse potentials and fitted to the Boltzmann function (Fig. 2A) . The activation curve showed that the threshold voltage for HERG current activation was close to Ϫ50 mV and that it was fully activated with voltage steps to ϩ10 mV. The rate of activation was similar before and after exposure to 100-mM SC. V 1/2 values were Ϫ17.7Ϯ1.5 mV in the control and Ϫ19.8Ϯ1.6 mV in SC ( pϾ0.05, nϭ12); the corresponding k values were 6. 8Ϯ0.2 and 6.5Ϯ0.2, respectively (pϾ0.05, nϭ12) . Thus, 100-mM SC had little effect on the voltage dependence of activation.
To measure inactivation, a special protocol was used that inactivated the channel at a holding potential of ϩ40 mV, recovered the channel from inactivation at various potentials from Ϫ120 to ϩ20 mV (12 ms) in 10-mV steps, and measured the resulting peak outward current at constant ϩ20 mV as a measure of steady-state inactivation (Fig. 2B) . Mean data from 12 cells were fitted with a Boltzmann function, yielding inactivation V 1/2 values of Ϫ70.9Ϯ3.0 mV in the control and Ϫ81.8Ϯ2.6 mV in 100-mM SC (pϽ0.05, nϭ12) (Fig. 2C) . The corresponding k values were Ϫ3.1Ϯ5.6 in the control and Ϫ13.8Ϯ5.5 in SC (pϽ0.05, nϭ12) . The time course of the development of inactivation was also assessed. There were no significant differences in V 1/2 or k at an SC concentration of 100 mM compared with the control (pϾ0.05). (B) Representative current tracing for steady-state inactivation using a double-pulse protocol with varying interpulse repolarization levels (from Ϫ120 to ϩ20 mV). (C) Normalized steady-state inactivation curves before and after exposure to 100-mM SC. (D) The time constant of inactivation was significantly reduced as the membrane potential increased from Ϫ120 to Ϫ20 mV (pϽ0.01). Solid lines represent fits to Boltzmann function. * pϽ0.05, * * pϽ0.01 vs. control.
Fig. 3. Effects of SC on Kinetic Time Constants (nϭ12)
(A) Representative current tracing for HERG current recovery from inactivation recorded at several test potentials (from Ϫ120 to ϩ30 mV) after a sustained depolarizing pulse to ϩ40 mV from a holding potential of Ϫ80 mV. (B) Representative current tracing for the onset of inactivation of the HERG current. The HERG channels were opened and inactivated by a step to ϩ40 mV from the holding potential of Ϫ80 mV. This was followed by a brief step (10 ms) to Ϫ100 mV to relieve inactivation and then a step to various test potentials (from Ϫ120 to ϩ30 mV), resulting in large, outward inactivating currents. The time constants for the onset of inactivation were obtained by fitting the exponential function to the decaying current traces during the third pulse of the protocol. (C) Onset-of-inactivation curves in the absence and presence of 100-mM SC (pϾ0.05). (D) Time constants for recovery from inactivation and for onset of inactivation were plotted against membrane potential (pϽ0.05). (E) Time constants for deactivation in the absence and presence of 100-mM SC (pϾ0.05). Solid lines represent fits of a single exponential function to the decending phase of the tail current. * pϽ0.05, * * pϽ0.01, * * * pϽ0.001 vs. control.
2D; nϭ12). From Ϫ120 to Ϫ20 mV, the time constants of inactivation were significantly smaller in the presence of 100-mM SC (pϽ0.01, nϭ12) than in the absence of the drug. To determine recovery from inactivation, the fully activated I-V protocol shown in Fig. 3A was used: a 2.5-s depolarizing pulse to ϩ40 mV to inactivate the HERG channels, followed by varying repolarizing pulses to test potentials between Ϫ120 and ϩ30 mV in 10-mV steps. The prepulse potential at ϩ40 mV was positive enough to induce full conductance of the HERG channels but also rendered a large number of the channels in the inactivated state. The rate of recovery from inactivation was obtained by fitting a single exponential to the initial increase in tail-current amplitude, whereas the time constant of deactivation was ascertained by fitting a single exponential to the decay of the tail current. The time constant of recovery from inactivation was significantly smaller in the presence of 100-mM SC (pϽ0.01, nϭ12) (Fig. 3D) . However, this concentration of SC did not change the deactivation rate significantly (pϾ0.05, nϭ12) (Fig. 3E) .
The effect of SC on the onset of inactivation of the HERG current was investigated using a three-pulse protocol. The channels were first inactivated by clamping the membrane at ϩ40 mV for 2.5 s, followed by a prepulse to Ϫ100 mV for 15 ms. This prepulse was sufficiently long to allow rapid recovery of channels from inactivation but short enough to prevent significant channel deactivation. Following the recovery prepulse, a series of test pulses were delivered to potentials ranging from Ϫ120 to ϩ30 mV, resulting in large, outward inactivating currents (Fig. 3B) . The onset-of-inactivation curves in the absence and presence of 100-mM SC are shown in Fig. 3C . The time constants for the onset of inactivation were obtained by fitting exponential function to the decaying current traces during the third pulse of the protocol, and were significantly decreased following perfusion with 100-mM SC (pϽ0.05, nϭ12) (Fig. 3D) .
Effects of SC on HERG Protein Levels Figure 4A shows Western blot analysis of membrane proteins in HEK293 cells stably transfected with HERG and in untransfected control cells. Antibody directed against the N terminus (anti-N) was used to probe for HERG protein. The anti-N antibodies recognized two bands of HERG protein in transfected cells: an upper band with an apparent molecular mass of ca. 155 kDa and a lower band with an apparent molecular mass of ca. 135 kDa (Fig. 4A, lane 2) . Neither band was present in untransfected HEK293 cells (Fig. 4A, lane 1) .
To test the effect of SC on the expression of HERG channels, HERG-transfected HEK293 cells were treated with 0 (control), 30, 100 or 300-mM SC for 24 h or 48 h. Western blot analysis was then performed (Fig. 4B) . There was no difference in the expression of HERG protein between the SC-treated groups and the control group after 24 h (data not shown). 30-mM and 100-mM SC had no effect on the expression of HERG protein after 48 h. Treatment with 300-mM SC led to the expression of lower levels of HERG protein, but the levels were not significantly lower than those in the control (pϾ0.05, nϭ6; Fig. 4C ).
The localization of HERG potassium channel proteins was then studied by immunofluorescence experiments (Fig. 5 ). Cells were plated for 48 h, fixed, and labeled with anti-HERG antibody; photographs were then taken with a confocal microscope and merged. It was found that HERG proteins mainly localized in the cell membrane surface compartment. As shown in Fig. 5 , there was no significant difference in fluorescence intensity between SC groups and control group, except for 300-mM SC group where fluorescence intensity was slightly weaker. This was coincident with results from Western blot analysis. 
DISCUSSION
To assess the cardiovascular safety of new drugs, their effects on HERG-encoded K ϩ channels are regularly examined using a whole-cell patch clamp method. 22) In this report, experiments were preformed in HEK293 cells that were stably transfected with HERG cDNA.
With regard to the relationship among the HERG current blockade, QT prolongation and TdP arrhythmia, Redfern and colleagues have provisionally recommended a 30-fold safety margin between maximal effective plasma concentration and observed HERG IC 50 . 5) In humans, the therapeutic free plasma concentration of SC is ca. 14.4 mM following a single i.v. injection of 6 mg/kg. 14, 15) The electrophysiological findings from this study show that SC blocked HERG channels in a concentration-dependent manner, with an IC 50 of 100-300 mM. This would yield a safety margin of 6.9-20.8, which is well within the range expected to be associated with TdP arrhythmia. This is consistent with the known anti-arrhythmic pharmacological activity of the SC analogs matrine and oxymatrine. 19, 24, 25) These data suggest that the potential cardiotoxicity of SC should be monitored with careful clinical examinations in future clinical trials. However, it is becoming increasingly evident that no single test is sufficient for assessing the risk of drug-induced TdP in humans. 26) At a given time, HERG channels exist in one of three main conformations: closed, open or inactive. Different drugs exhibit different affinities for the three states. Under the conditions of our experiment, SC exhibited voltage-dependent channel inhibition, with the enhancement of block at positive potentials coinciding with the activation of the channel (Fig.  1B) . It is thought that HERG channel inactivation has an important role in channel block by some (but not all) drugs, either by increasing drug-binding affinity or by facilitating the optimal orientation of the S6 aromatic residues to which drugs bind. [27] [28] [29] In this study, the extent of channel inactivation was significantly altered (Fig. 2C ) and the time course of inactivation seemed to be accelerated (Fig. 2D) . Furthermore, the time constants for the onset of inactivation were significantly smaller following perfusion with SC (Fig. 3D) . These effects of SC on channel kinetics were consistent with affinity for the inactivated state. However, an unequivocal distinction between SC interaction with the open and the inactivated states of the HERG channel cannot be made.
Previous studies have shown that some drugs, such as pentamidine, fluoxetine and norfluoxetine, causing QT interval prolongation can selectively reduce I Kr by disrupting protein trafficking and channel maturation, rather than by direct block of surface membrane channels. [30] [31] [32] In this paper, we had investigated the effects of SC on HERG surface membrane expression by Western blot analysis and immunofluorescence methods.
Many channel proteins show more than one band on Western blot analyses, an occurrence often attributed to glycosylation of the channel protein in the endoplasmic reticulum and Golgi apparatus. 33) In our study, two HERG protein bands were detected in the Western blot analysis of HERGtransfected HEK293 cells (Fig. 4A) : a 135-kDa band representing the core-glycosylated, immature form of the channel protein located in the endoplasmic reticulum, and a 155-kDa band representing the fully glycosylated, mature form of the channel protein located in the plasma membrane. 34) Our results show that both the 135-kDa band and the 155-kDa band were present when the cells were cultured for 24 h or 48 h in the absence or presence of SC. In addition, SC had no significant effect on the expression of HERG protein. These findings indicate that SC does not affect the processing of the core-glycosylated, immature form of the channel protein to the fully glycosylated, mature form. In other words, SC has no effect on the generation and trafficking of HERG protein.
In summary, SC is a potent blocker of HERG K ϩ channels that functions by changing channel inactivation kinetics. In addition, SC has no effect on the generation and trafficking of HERG protein.
